Spermidine requirement for cell proliferation in eukaryotic cells: structural specificity and quantitation

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Alpha-difluoromethylornithine (DFMO) inhibits putrescine biosynthesis, leading to cytostasis in L1210 leukemia cells.
• Polyamines like spermidine and putrescine are essential for cell growth and proliferation.
• Understanding polyamine transport and metabolism is crucial for developing cancer therapies.

Purpose of the Study:

• To investigate the structural requirements for spermidine and putrescine analogs to overcome DFMO-induced cytostasis.
• To define the structural specificity of the spermidine carrier system in L1210 cells.
• To determine the minimum polyamine levels required for cell proliferation under DFMO treatment.

Main Methods:

• Cultured L1210 leukemia cells were treated with DFMO and various structural homologs of spermidine and putrescine.
• High-performance liquid chromatography (HPLC) was used to analyze polyamine uptake.
• Competition studies with spermidine were performed to assess carrier specificity.

Main Results:

• Three of six spermidine homologs and two of five putrescine homologs supported cell growth in the presence of DFMO.
• Cellular uptake of homologs was confirmed, indicating the involvement of the spermidine carrier.
• A two-carbon extension of the spermidine structure was tolerated for biological activity, but diamines were ineffective.
• Only 15% of normal spermidine levels were needed for proliferation under DFMO treatment.

Conclusions:

• The central nitrogen atom in spermidine is essential for its biological function in preventing DFMO-induced cytostasis.
• Specific structural features of spermidine and putrescine analogs influence their ability to be transported and utilized by L1210 cells.
• These findings provide insights into polyamine transport mechanisms and potential therapeutic strategies targeting polyamine metabolism in leukemia.